|
A549-ACE-2克隆8-TMPRSS2101006
|
EA
|
101006
|
1717
|
1-4/12周
|
|
SARS-CoV-2传染性病毒[CVR-GLA1]100998
|
EA
|
100998
|
1717
|
1-4/12周
|
|
SARS-CoV-2传染性病毒[CVR-GLA2]100999
|
EA
|
100999
|
1717
|
1-4/12周
|
|
SARS-CoV-2传染性病毒[CVR-GLA3]101000
|
EA
|
101000
|
1717
|
1-4/12周
|
|
pCRII-SARS-CoV-2[ORF3a-ORF6]100996
|
EA
|
100996
|
1717
|
1-4/12周
|
|
pCRII-SARS-CoV-2[NSP15-NSP16]100994
|
EA
|
100994
|
1717
|
1-4/12周
|
|
VeroE6-ACE2101001
|
EA
|
101001
|
1717
|
1-4/12周
|
|
灭活SARS-CoV-2的核酸提取物[BetaCoV/澳大利亚/VIC01/2020100988
|
EA
|
100988
|
1717
|
1-4/12周
|
|
pCAGGS-SARS-CoV-2-Spike布里斯托尔缺失100986
|
EA
|
100986
|
1717
|
1-4/12周
|
|
灭活SARS-CoV-2[BetaCoV/澳大利亚/VIC01/2020100987
|
EA
|
100987
|
1717
|
1-4/12周
|
|
pCRII-SARS-CoV-2[NSP4-NSP8]100991
|
EA
|
100991
|
1717
|
1-4/12周
|
|
pCRII-SARS-CoV-2[NSP4-NSP8]100992
|
EA
|
100992
|
1717
|
1-4/12周
|
|
pCRII-SARS-CoV-2[5'UTR-NSP2]100989
|
EA
|
100989
|
1717
|
1-4/12周
|
|
白喉抗毒素人IgG[第1批国际标准]10/262
|
EA
|
10/262
|
4988
|
1-4/12周
|
|
SARS-CoV-2传染性病毒[BetaCoV/澳大利亚/VIC01/2020100980
|
EA
|
100980
|
1717
|
1-4/12周
|
|
pCAGGS_SARS-CoV-2_SpikeD614G100985
|
EA
|
100985
|
1717
|
1-4/12周
|
|
Moreau-RJ亚株卡介苗[第1批WHO参考试剂]10/272
|
EA
|
10/272
|
4988
|
1-4/12周
|
|
VeroE6/TMPRSS2100978
|
EA
|
100978
|
1717
|
1-4/12周
|
|
pCAGGS-SARS-CoV-2-刺突100976
|
EA
|
100976
|
1717
|
1-4/12周
|
|
血型基因分型参考试剂RBC5[Brr][WHO参考试剂]10/238
|
EA
|
10/238
|
4988
|
1-4/12周
|